FYB — Formycon AG Income Statement
0.000.00%
Last trade - 00:00
- €832.52m
- €804.47m
- €42.50m
2018 December 31st | 2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | GAS | GAS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 43.2 | 33.9 | 34.3 | 36.6 | 42.5 |
Cost of Revenue | |||||
Gross Profit | 18.9 | 11.7 | 7.63 | 9.87 | 12.1 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 36.1 | 36.2 | 40.8 | 50.6 | 60.2 |
Operating Profit | 7.13 | -2.27 | -6.54 | -14 | -17.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 7.1 | -2.3 | -6.64 | -14.2 | 36.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 7.1 | -2.29 | -6.73 | -13.3 | 36 |
Net Income Before Extraordinary Items | |||||
Net Income | 7.1 | -2.29 | -6.73 | -13.3 | 36 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 7.1 | -2.29 | -6.73 | -13.3 | 36 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.77 | -0.214 | -0.612 | -1.21 | 2.59 |
Dividends per Share |